Fedratinib Hydrochloride and Ticagrelor
Determining the interaction of Fedratinib Hydrochloride and Ticagrelor and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: The concomitant use of ticagrelor with other platelet inhibitors, anticoagulants, thrombolytic agents, or nonsteroidal anti-inflammatory drugs may increase the risk of bleeding. MANAGEMENT: Caution is recommended when these drugs are used concomitantly with ticagrelor or within 24 hours of ticagrelor dosing. Patients should be advised to promptly report any signs of bleeding to their doctor, including pain, swelling, headache, dizziness, weakness, prolonged bleeding from cuts, increased menstrual flow, vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or brown urine, or red or black stools. References Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 "Product Information. Brilinta (ticagrelor)." Astra-Zeneca Pharmaceuticals, Wilmington, DE.
Professional:MONITOR: The concomitant use of ticagrelor with other platelet inhibitors, anticoagulants, thrombolytic agents, or nonsteroidal anti-inflammatory drugs may increase the risk of bleeding.
MANAGEMENT: Caution is recommended when these drugs are used concomitantly with ticagrelor or within 24 hours of ticagrelor dosing. Patients should be advised to promptly report any signs of bleeding to their doctor, including pain, swelling, headache, dizziness, weakness, prolonged bleeding from cuts, increased menstrual flow, vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or brown urine, or red or black stools.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Brilinta (ticagrelor)." Astra-Zeneca Pharmaceuticals, Wilmington, DE.
Generic Name: fedratinib
Brand name: Inrebic
Synonyms: Fedratinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fedratinib Hydrochloride-Ticalast
- Fedratinib Hydrochloride-Ticanase
- Fedratinib Hydrochloride-Ticar
- Fedratinib Hydrochloride-Ticarcillin and clavulanate Intravenous
- Fedratinib Hydrochloride-Ticarcillin and Clavulanate Potassium
- Fedratinib Hydrochloride-Ticaspray
- Ticagrelor-Feiba
- Ticagrelor-Feiba NF
- Ticagrelor-Feiba VH Immuno
- Ticagrelor-Feiba-VH
- Ticagrelor-Felbamate
- Ticagrelor-Felbamate Oral Suspension